DEMODEX BLEPHARITIS

Clinical trials for DEMODEX BLEPHARITIS explained in plain language.

Never miss a new study

Get alerted when new DEMODEX BLEPHARITIS trials appear

Sign up with your email to follow new studies for DEMODEX BLEPHARITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New eye drop targets common eyelid infection

Disease control Recruiting now

This study is testing a new medication called GLK-321 for people with Demodex blepharitis, a common eyelid condition caused by tiny mites. About 250 participants will be randomly assigned to receive either the active treatment or a placebo eye drop for 6 weeks. The main goal is t…

Matched conditions: DEMODEX BLEPHARITIS

Phase: PHASE2 • Sponsor: Glaukos Corporation • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

DEMODEX BLEPHARITIS

Get alerted when new DEMODEX BLEPHARITIS trials appear

New eye drop targets common eyelid infection